Drug Eye Africa

ANAMEV publishes procedure for submitting marketing authorisation applications

The Agence Nationale des Médicaments et des Évacuations Sanitaires (ANAMEV) has published guidance on submitting marketing authorisation (AMM) applications for pharmaceutical and cosmetic products.

Applicants may submit dossiers electronically to reglementation@anamev.org or in person at the ANAMEV Homologation Service, also in electronic format. Reception hours are Monday to Thursday 08:00 to 17:00 and Friday 08:00 to 12:00.

All submissions require pre-payment of regulatory fees. No dossier will be registered without this payment.

Required documents vary by product type. Detailed lists for generics, branded medicines, vaccines, herbal products, food supplements and medical devices, along with application forms, are available on the ANAMEV website under “Homologation et essai clinique”.

Source: Agence Nationale des Médicaments et des Évacuations Sanitaires (ANAMEV), “Comment déposer un dossier d’AMM auprès de l’ANAMEV”, 23 September 2026: https://www.anamev.org/actualite.php?id=34

About the author

Drug Eye Africa Newsroom

Drug Eye Africa Newsroom

The Drug Eye Africa newsroom reports on medicines regulation, recalls and medicine quality across the African continent. Alerts are matched against the issuing authority's published notice before publication, and corrections are timestamped on the article rather than made silently.

Regulatory alerts and news, direct to your inbox

Independent pharmaceutical news and regulatory intelligence covering Africa.

Scroll to Top